Clinical Trials Logo

Clinical Trial Summary

48-hour application of metal allergen patches to test for potential allergic responses.


Clinical Trial Description

A 48-hour application (approximate) of investigational allergen panels, excipient controls and corresponding reference allergens will be applied to the skin of human subjects to test for potential positive allergic responses. Test sites will be evaluated at 3-4, 7-8, 10-14 and 19-23 days after application. Ascending allergen dosages will be randomized within each panel into three different configurations which will be randomly assigned to subjects as they enter the study. The investigators and subjects will be aware of the allergens and the patch test doses but will not be aware of the location of individual allergens within each panel. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02615249
Study type Interventional
Source Allerderm
Contact
Status Completed
Phase Phase 2
Start date December 5, 2016
Completion date July 15, 2019

See also
  Status Clinical Trial Phase
Completed NCT03139981 - A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis Phase 1